Pembrolizumab in relapsed or refractory Richter syndrome

被引:38
作者
Armand, Philippe [1 ]
Murawski, Niels [2 ]
Molin, Daniel [3 ]
Zain, Jasmine [4 ]
Eichhorst, Barbara [5 ]
Gulbas, Zafer [6 ]
Hawkes, Eliza A. [7 ]
Pagel, John M. [8 ]
Phillips, Tycel [9 ]
Ribrag, Vincent [10 ]
Svoboda, Jakub [11 ]
Stathis, Anastasios [12 ]
Chatterjee, Arkendu [13 ]
Orlowski, Robert [13 ]
Marinello, Patricia [13 ]
Christian, Beth [14 ,15 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Klinikum Saarlandes Innere Med I, Homburg, Germany
[3] Uppsala Univ, Dept Immunol Genet & Pathol, Expt & Clin Oncol, Uppsala, Sweden
[4] City Hope Natl Med Ctr, Duarte, CA USA
[5] Univ Cologne, Cologne, Germany
[6] Anadolu Med Ctr, Istanbul, Turkey
[7] Austin Hlth, Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia
[8] Swedish Canc Inst, Swedish Ctr Blood Disorders & Stem Cell Transplan, Seattle, WA USA
[9] Rogel Canc Ctr, Ann Arbor, MI USA
[10] Inst Gustave Roussy, Villejuif, France
[11] Univ Penn, Perelman Ctr Adv Med, Philadelphia, PA 19104 USA
[12] Oncol Inst Southern Switzerland, Bellinzona, Switzerland
[13] Merck & Co Inc, Kenilworth, NJ USA
[14] Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA
[15] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA
关键词
chronic lymphocytic leukaemia; immunotherapy; PD-1; pembrolizumab; Richter syndrome; LYMPHOMA; TRANSFORMATION; OUTCOMES; CLL;
D O I
10.1111/bjh.16762
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E117 / E120
页数:4
相关论文
共 14 条
[1]   Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma [J].
Armand, Philippe ;
Rodig, Scott ;
Melnichenko, Vladimir ;
Thieblemont, Catherine ;
Bouabdallah, Kamal ;
Tumyan, Gayane ;
Ozcan, Muhit ;
Portino, Sergio ;
Fogliatto, Laura ;
Caballero, Maria D. ;
Walewski, Jan ;
Gulbas, Zafer ;
Ribrag, Vincent ;
Christian, Beth ;
Perini, Guilherme Fleury ;
Salles, Gilles ;
Svoboda, Jakub ;
Zain, Jasmine ;
Patel, Sanjay ;
Chen, Pei-Hsuan ;
Ligon, Azra H. ;
Ouyang, Jing ;
Neuberg, Donna ;
Redd, Robert ;
Chatterjee, Arkendu ;
Balakumaran, Arun ;
Orlowski, Robert ;
Shipp, Margaret ;
Zinzani, Pier Luigi .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (34) :3291-+
[2]   Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087 [J].
Chen, Robert ;
Zinzani, Pier Luigi ;
Lee, Hun Ju ;
Armand, Philippe ;
Johnson, Nathalie A. ;
Brice, Pauline ;
Radford, John ;
Ribrag, Vincent ;
Molin, Daniel ;
Vassilakopoulos, Theodoros P. ;
Tomita, Akihiro ;
von Tresckow, Bastian ;
Shipp, Margaret A. ;
Lin, Jianxin ;
Kim, Eunhee ;
Nahar, Akash ;
Balakumaran, Arun ;
Moskowitz, Craig H. .
BLOOD, 2019, 134 (14) :1144-1153
[3]   Revised response criteria for malignant lymphoma [J].
Cheson, Bruce D. ;
Pfistner, Beate ;
Juweid, Malik E. ;
Gascoyne, Randy D. ;
Specht, Lena ;
Horning, Sandra J. ;
Coiffier, Bertrand ;
Fisher, Richard I. ;
Hagenbeek, Anton ;
Zucca, Emanuele ;
Rosen, Steven T. ;
Stroobants, Sigrid ;
Lister, T. Andrew ;
Hoppe, Richard T. ;
Dreyling, Martin ;
Tobinai, Kensei ;
Vose, Julie M. ;
Connors, Joseph M. ;
Federico, Massimo ;
Diehl, Volker .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :579-586
[4]   Autologous and Allogeneic Stem-Cell Transplantation for Transformed Chronic Lymphocytic Leukemia (Richter's Syndrome): A Retrospective Analysis From the Chronic Lymphocytic Leukemia Subcommittee of the Chronic Leukemia Working Party and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation [J].
Cwynarski, Kate ;
van Biezen, Anja ;
de Wreede, Liesbeth ;
Stilgenbauer, Stephan ;
Bunjes, Donald ;
Metzner, Bernd ;
Koza, Vladimir ;
Mohty, Mohamad ;
Remes, Kari ;
Russell, Nigel ;
Nagler, Arnon ;
Scholten, Marijke ;
de Witte, Theo ;
Sureda, Anna ;
Dreger, Peter .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (18) :2211-2217
[5]   Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma [J].
Davids, Matthew S. ;
Roberts, Andrew W. ;
Seymour, John F. ;
Pagel, John M. ;
Kahl, Brad S. ;
Wierda, William G. ;
Puvvada, Soham ;
Kipps, Thomas J. ;
Anderson, Mary Ann ;
Salem, Ahmed Hamed ;
Dunbar, Martin ;
Zhu, Ming ;
Peale, Franklin ;
Ross, Jeremy A. ;
Gressick, Lori ;
Desai, Monali ;
Kim, Su Young ;
Verdugo, Maria ;
Humerickhouse, Rod A. ;
Gordon, Gary B. ;
Gerecitano, John F. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08) :826-833
[6]   Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL [J].
Ding, Wei ;
LaPlant, Betsy R. ;
Call, Timothy G. ;
Parikh, Sameer A. ;
Leis, Jose F. ;
He, Rong ;
Shanafelt, Tait D. ;
Sinha, Sutapa ;
Le-Rademacher, Jennifer ;
Feldman, Andrew L. ;
Habermann, Thomas M. ;
Witzig, Thomas E. ;
Wiseman, Gregory A. ;
Lin, Yi ;
Asmus, Erik ;
Nowakowski, Grzegorz S. ;
Conte, Michael J. ;
Bowen, Deborah A. ;
Aitken, Casey N. ;
Van Dyke, Daniel L. ;
Greipp, Patricia T. ;
Liu, Xin ;
Wu, Xiaosheng ;
Zhang, Henan ;
Secreto, Charla R. ;
Tian, Shulan ;
Braggio, Esteban ;
Wellik, Linda E. ;
Micallef, Ivana ;
Viswanatha, David S. ;
Yan, Huihuang ;
Chanan-Khan, Asher A. ;
Kay, Neil E. ;
Dong, Haidong ;
Ansell, Stephen M. .
BLOOD, 2017, 129 (26) :3419-3427
[7]   Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma [J].
Green, Michael R. ;
Monti, Stefano ;
Rodig, Scott J. ;
Juszczynski, Przemyslaw ;
Currie, Treeve ;
O'Donnell, Evan ;
Chapuy, Bjoern ;
Takeyama, Kunihiko ;
Neuberg, Donna ;
Golub, Todd R. ;
Kutok, Jeffery L. ;
Shipp, Margaret A. .
BLOOD, 2010, 116 (17) :3268-3277
[8]  
HILLMEN P, 2016, BLOOD, V128
[9]   Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma [J].
Kuruvilla, John ;
Savona, Michael ;
Baz, Rachid ;
Mau-Sorensen, Paul Morten ;
Gabrail, Nashat ;
Garzon, Ramiro ;
Stone, Richard ;
Wang, Michael ;
Savoie, Lynn ;
Martin, Peter ;
Flinn, Ian ;
Jacoby, Meagan ;
Unger, Thaddeus J. ;
Saint-Martin, Jean-Richard ;
Rashal, Tami ;
Friedlander, Sharon ;
Carlson, Robert ;
Kauffman, Michael ;
Shacham, Sharon ;
Gutierrez, Martin .
BLOOD, 2017, 129 (24) :3175-3183
[10]   Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma [J].
Parikh, Sameer A. ;
Habermann, Thomas M. ;
Chaffee, Kari G. ;
Call, Timothy G. ;
Ding, Wei ;
Leis, Jose F. ;
Macon, William R. ;
Schwager, Susan M. ;
Ristow, Kay M. ;
Porrata, Luis F. ;
Kay, Neil E. ;
Slager, Susan L. ;
Shanafelt, Tait D. .
AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (04) :334-338